secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
CIK:        0001310488
Form:       8-K
Filed at:   2026-08-14T19:23:23+00:00
Accession:  0001091818-26-000124
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioForce NanoSciences appoints interim CEO, adds director and advisory board members
--------------------------------------------------------------------------------

- Richard Kaiser appointed interim CEO on June 17, 2026; he remains CFO, Secretary, and Director.
- Scott Mager appointed General Counsel on May 19, 2026, and Director on June 15, 2026.
- Advisory Board established May 19, 2026; Stuart Yarbrough and Edward Mathias appointed for 3-year terms ending May 19, 2029.
- Yarbrough is CPA with 20+ years at Ernst & Young and BDO; Mathias is senior advisor to Carlyle Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000124/0001091818-26-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000124/bfnh-08142026_8k.htm
  HTML page:      https://secwatch.observer/filing/0001091818-26-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer